Carl Hull, Paul Hawran, Gregory Schiffman, Sheila Robertson, Jai Nagarkatti, Franklin Wicks, David Julien, Lee Hood | GenomeWeb
Gen-Probe has hired Carl Hull as executive vice president and COO, the company said this week.
 
Hull recently was at Applied Biosystems, where he served as vice president and general manager of the company’s Sequence Detection System and Microarray business unit.
 
Hull also was a CEO at Applied Imaging and he worked in marketing and sales at Ventana Medical Systems and at Abbott Laboratories.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.